Ondas Holdings Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

Stockholders’ Equity (Details) - USD ($)						1 Months Ended						3 Months Ended		12 Months Ended
Stockholders’ Equity (Details) - USD ($)	Feb. 07, 2022	Oct. 05, 2021	Jul. 11, 2021	Jun. 08, 2021	Jan. 08, 2021	Apr. 30, 2022	Mar. 22, 2022	Mar. 22, 2022	Mar. 18, 2022	Jan. 29, 2021	Jan. 25, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Nov. 05, 2021	Aug. 05, 2021	Dec. 31, 2018
Stockholders’ Equity (Details) [Line Items]
Common stock, authorized												116,666,667		116,666,667
Common stock par value (in Dollars per share)							$ 0.0001	$ 0.0001				$ 0.0001		$ 0.0001
Common stock, shares issued												40,990,604		40,990,604
Common stock, shares outstanding												40,990,604		40,990,604
Preferred stock, shares (in Dollars per share)												$ 10,000,000		$ 10,000,000
Preferred stock, par value (in Dollars per share)												$ 0.0001		$ 0.0001
Preferred stock, authorized												5,000,000		5,000,000
Certificate of designation series A preferred stock												5,000,000		5,000,000
Public offering, description				the Company entered into an underwriting agreement (the “2021 Underwriting Agreement”) with Oppenheimer & Co. Inc., acting as the representative for the underwriters identified therein (the “Underwriters”), relating to the Company’s public offering (the “2021 Public Offering”) of 6,400,000 shares (the “2021 Firm Shares”) of the Company’s Common Stock. Pursuant to the 2021 Underwriting Agreement, the Company also granted the Underwriters a 30-day option to purchase up to an additional 960,000 shares of Common Stock (the “2021 Option Shares,” and together with the 2021 Firm Shares, the “2021 Shares”) to cover over-allotments.The Underwriters agreed to purchase the 2021 Firm Shares from the Company with the option to purchase the 2021 Option Shares at a price of $6.51 per share. The 2021 Shares were offered, issued, and sold pursuant to the Form S-3 and accompanying prospectus filed with the SEC under the Securities Act.	On June 11, 2021, pursuant to the 2021 Public Offering, the Company issued 7,360,000 shares of Common Stock (2021 Firm Shares and 2021 Option Shares) at a public price of $7.00 for net proceeds to the Company of $47,523,569 after deducting the underwriting discount and offering fees and expenses payable by the Company.
Option shares at price per share (in Dollars per share)												$ 6.51
Common stock, shares issued			7,360,000
Net proceeds (in Dollars)			$ 7
Deducting the underwriting discount (in Dollars)			$ 47,523,569
Sales amount (in Dollars)								$ 50,000,000
Percentage of gross proceeds												3.00%
Compensation paid by agent (in Dollars)												$ 77,421
Warrants outstanding to purchase an aggregate												3,305,854
Options term												5 years
Weighted average exercise price (in Dollars per share)												$ 8.53
Aggregate of purchase shares												3,015
Stock options to purchase shares	1,248,000	3,141,098
Compensation expense related to non-vested options (in Dollars)												$ 4,672,000
Weighted-average period												5 years 3 months 14 days
Stock based compensation (in Dollars)												$ 332,642	$ 97,162
Restricted stock							14,800
Restricted stock units (in Dollars)												90,563
Unrecognized compensation expense (in Dollars)												$ 271,689
Restricted stock units description																the Company entered into employment agreements and awarded 1,375,000 restricted stock units pursuant to the 2018 Plan to key members of American Robotics’ management. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The restricted stock units vest in three successive equal annual installments with the first vesting date commencing on the first anniversary of the award date and are contingent on continuing employment. The compensation expense recognized in the three months ended March 31, 2022 in respect of these restricted stock units was $872,734, and as of March 31, 2022 the unrecognized compensation expense was $8,372,381.
Compensation committee, description											the Compensation Committee approved the following grants: (a) for Messrs. Cohen, Reisfield and Silverman (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (b) for Mr. Seidl and Ms. Sood (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (ii) 10,000 restricted stock units pursuant to the 2018 Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The 5,000 restricted stock units granted to each of Messrs. Cohen, Reisfield, Silverman and Seidl and Ms. Sood vest in four successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. The 10,000 restricted stock units granted to Mr. Seidl and Ms. Sood vest in eight successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. All restricted stock units granted to these directors shall vest in full immediately upon a change in control. The Company recognized stock-based compensation of $31,800 for the three months ended March 31, 2022. As of March 31, 2022, the unrecognized compensation expense was $95,400.
Equity Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock reserved for issuance																	3,333,334
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock, authorized												116,666,667
Common stock par value (in Dollars per share)												$ 0.0001
Common stock, shares issued												40,990,604
Common stock, shares outstanding												40,990,604
Restricted Stock Units (RSUs) [Member]
Stockholders’ Equity (Details) [Line Items]
Restricted stock units (in Dollars)												$ 656
Unrecognized compensation expense (in Dollars)												$ 105,756
Certain employees.[Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate of purchase shares									135,000
Certain non-employees [Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate of purchase shares									65,000
Two non-employees [Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate of purchase shares									210,000
Subsequent Event [Member]
Stockholders’ Equity (Details) [Line Items]
Net proceeds (in Dollars)						$ 2,500,000
ATM shares						343,045
Sales average price (in Dollars per share)						$ 7.72
Equity Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock reserved for issuance												6,000,000
Restricted Stock Units (RSUs) [Member]
Stockholders’ Equity (Details) [Line Items]
Compensation committee grants															6,362
Investor [Member] \| Securities Purchase Agreement [Member] \| Over-Allotment Option [Member]
Stockholders’ Equity (Details) [Line Items]
Description of transaction										the Company filed a shelf Registration Statement on Form S-3 for up to $150,000,000 with the SEC (the “Form S-3”) for shares of its Common Stock; shares of its preferred stock, which the Company may issue in one or more series or classes; debt securities, which the company may issue in one or more series; warrants to purchase its Common Stock, preferred stock or debt securities; and units. The Form S-3 was declared effective by the SEC on February 5, 2021.